ThromboGenomics in The Bulletin of The Royal College of Pathologists

The ThromboGenomics consortium describe the use of high throughput sequencing to identify rare variants in genes encoding proteins involved in disorders of haemostasis. This can provide a definite genetic basis for patients with platelet functional disorders of uncertain aetiology. What is particularly impressive is the speed with which this technology has been translated from the research environment to the clinic.

RCPath_April_2016_Bulletin_pg86-90 (.ppt)